Credit: John Earle Photography
Luk H. Vandenberghe, Ph.D., Director of the Grousbeck Gene Therapy Center at Mass. Eye and Ear, is a co-founder of Odylia Therapeutics, a nonprofit dedicated to accelerating drug development for ultra-rare genetic conditions causing blindness.